Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, YSS Corp. (TSX.V: YSS) (WKN: A2PMAX), has received its 12th cannabis retail license from the Alberta Gaming, Liquor and Cannabis Commission (“AGLC”).…
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that Edgardo “Ed” Baracchini, Ph.D., has joined its board of directors. Per…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced successful completion of its Master Collaborative Research Agreement (“the R&D Program”) with the National Research Council of Canada (“NRC”). The…
Earth Science Tech operates through diverse subsidiaries in the CBD space The company offers a wide range of CBD products, as well as its MSN-2 medical device ETST has varied distribution agreements in place to…
INmune Bio is currently attending the Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit in Boston Co-founder and CEO Dr. RJ Tesi is presenting positive preliminary data on INB03, which is being developed as part of…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced that it has applied to list its common shares on the NASDAQ under the symbol ‘TGOD’. The listing…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced that it will host a conference call at 1:00 PM Eastern Daylight Time on Wednesday, August 14,…
Lexaria’s patented DehydraTECH technology improves taste, achieves higher absorption rates and promotes fast onset of bioactive compounds, including nicotine and cannabinoids Nine corporate licensees have signed a total of 11 definitive contracts to use DehydraTECH technology…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced that it anticipates opening its 100th Seventh Sense Botanical Therapy mall-based shop on Thursday, August 8. The first Seventh Sense shop opened in…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that its manufacturing partner, Aldevron, has successfully completed the manufacturing of the TUSC2 (Tumor Suppressor Candidate 2) plasmid DNA per the manufacturing agreement between the…
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), has entered a definitive agreement to acquire Ilera Healthcare, a vertically-integrated cannabis cultivator, processor, and…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, today announced its plans to release its second quarter 2019 earnings after market close on Tuesday, August 13, 2019. The…
Pressure BioSciences (OTCQB: PBIO) recently launched its BaroShear K45 system which is based on the company’s proprietary Ultra Shear Technology (“UST”) platform. The innovative system has been optimized for the unique purpose of producing high…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) is a leading-edge producer, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. A recent article discussing the company reads, “Founded…
Lexaria Bioscience’s revolutionary DehydraTECH technology enables cannabis consumers to experience rapid-on, rapid-off effects in non-smoked formulations A just-announced joint manufacturing partnership between Lexaria and alcohol-free beverage maker Hill Street Beverage Company is paving the way…
Blue Hat reported 52 percent revenue growth and 76 percent net income growth for the nine months ended September 30, 2018 The company maintains a vast portfolio of proprietary technologies, patents, artwork copyrights, trademarks and…
INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today reported positive preliminary data during a presentation at Cambridge Healthtech Institute’s Seventh…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, recently provided a working benchtop Ultra Shear Technology (“UST”)…
INmune Bio attended the 17th Annual Congress of International Drug Discovery Science & Technology in Japan Co-founder and CEO R.J. Tesi and Director of Neuroscience C.J. Barnum both participated in talks about the role of…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced its successful renewal of its Health Canada licenses for the company’s Ancaster, Ontario facility. According to the update and…
Retail sales of toys and games in China soared from RMB111.8 billion in 2012 to RMB276.6 billion in 2017, registering an average annual growth rate of nearly 20 percent Favorable Chinese government policies emphasize the…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that it has engaged Integra Consulting Group LLC to provide investor relations services to the company in compliance with…
The company’s priority is on research and development of innovative hemp extracts ETST aims to be a global supplier of hemp oil enriched with CBD Its product sales were up 66 percent for the year…
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company Radicle Medical Marijuana Inc. has received Health Canada approval for its production facility expansion project. According to the update, the approval…
INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Co-Founder and CEO RJ Tesi, M.D. will present…
A strategic partnership is expected to enable Blue Hat to modernize classrooms across Guangzhou, China Through the agreement, Blue Hat will begin the development of augmented reality solutions for the education sector VR and AR…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced that its CLR Roasters has hired 35-year industry veteran Omar Peraza to lead the company’s food service…
Lifestyle-oriented cannabis company Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) today announced the completion of its previously disclosed acquisition of Spring Oaks Greenhouses, Inc., per the terms detailed on July 29, 2019. According to…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular augmented reality interactive entertainment games and toys in China, today announced the July 30, 2019 closing of its underwritten initial public…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced it has initiated the first phase of branding its lead drug candidate, Oncoprex(TM) immunogene therapy, and has completed and submitted non-proprietary drug name selections to…
PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized bioavailability CBD sales are projected to reach $89 billion by 2024 with a…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today reported on its existing technology licensees that have entered definitive contracts to use its revolutionary DehydraTECH(TM) absorption technology within their existing…
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF), a lifestyle-oriented cannabis company, on Monday announced an amendment to the share purchase agreement dated June 3, 2019 with Spring Oaks Greenhouses, Inc. Per the amended agreement, GGBXF…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, recently obtained approval from Health Canada for the licensing of all of the company’s Phase 4A buildout plans,…
California-based INmune Bio is developing therapies to battle cancers and Alzheimer’s disease by more effectively engaging the body’s own natural defenses Research published in a peer-reviewed scientific journal shows a mechanism by which scientists can…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, remains dedicated to maintaining its high standards in the midst of a growing cannabis supply gap. An article discussing the…
China’s AR industry is estimated at RMB$55 billion in 2020 Favorable Chinese government policies emphasize research and development of new technologies such as AR Few direct competitors in China create exceptional potential for AR application…
Organigram’s proprietary nano-emulsion technology is expected to provide an initial onset of effects within 10 to 15 minutes for cannabis beverages The company’s shelf-stable, thermally stable, water-compatible and palatable cannabinoid nano-emulsion formulation allows for the…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has entered into an advance payment and purchase agreement with 703454 N.B. Inc.…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the initial sale of its revolutionary BaroShear(TM)…